Pfizer Balance Sheet

NYSE: PFEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

28.28+0.46 (+1.65%)

At close: Oct 9, 4:01 PM ET · Delayed 15 min

Pfizer financial position

At the end of fiscal 2025, Pfizer reported total assets of $208.16 billion, down 2.5% from a year earlier against total liabilities of $121.39 billion. Shareholders' equity stood at $86.48 billion, or 41.5% of assets. The company held $1.14 billion in cash and equivalents against $64.80 billion of debt, a net debt position of $63.65 billion.

The current ratio (current assets divided by current liabilities) was 1.16, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.75.

Summary generated from market data by MetaCap's automated system. Methodology

Pfizer balance sheet (annual)

Pfizer annual balance sheet
Fiscal year (USD)	FY 20252025-12-31	FY 20242024-12-31	FY 20232023-12-31	FY 20222022-12-31	FY 20212021-12-31	FY 20202020-12-31	FY 20192019-12-31	FY 20182018-12-31	FY 20172017-12-31	FY 20162016-12-31
Cash & Equivalents	1.14B	1.04B	2.85B	416.00M	1.94B	1.79B	1.12B	1.14B	1.34B	2.60B
Short-Term Investments	9.18B	10.88B	4.40B	18.74B	22.01B	10.44B	8.53B	17.69B	18.65B	15.26B
Receivables	11.87B	11.46B	11.57B	10.95B	11.48B	7.91B	6.77B	8.03B	8.22B	8.22B
Inventory	10.65B	10.85B	10.19B	8.98B	9.06B	8.02B	7.07B	7.51B	7.58B	6.78B
Total Current Assets	42.90B	50.36B	43.33B	51.26B	59.69B	35.07B	32.80B	49.93B	41.14B	38.95B
Property, Plant & Equipment	19.32B	18.39B	18.94B	16.27B	14.88B	13.74B	12.97B	13.38B	13.87B	13.32B
Goodwill	71.26B	68.53B	67.78B	51.38B	49.21B	49.56B	48.18B	42.93B	55.95B	54.45B
Intangible Assets	53.73B	55.41B	64.90B	43.37B	25.15B	28.34B	33.94B	35.21B	48.74B	52.65B
Long-Term Investments	1.00M	2.23B	15.37B	15.07B	21.53B	20.26B	20.15B	2.59B	7.01B	7.12B
Total Assets	208.16B	213.40B	226.50B	197.21B	181.48B	154.23B	167.59B	159.42B	171.80B	171.62B
Accounts Payable	5.24B	5.63B	6.71B	6.81B	5.58B	4.28B	3.89B	4.67B	4.66B	4.54B
Short-Term Debt	3.15B	6.95B	10.35B	2.94B	2.24B	2.70B	16.20B	8.83B	9.95B	10.69B
Total Current Liabilities	36.98B	42.99B	47.79B	42.14B	42.67B	25.92B	37.30B	31.86B	30.43B	31.11B
Long-Term Debt	61.64B	57.41B	61.54B	32.88B	36.20B	37.13B	35.95B	32.91B	33.54B	31.40B
Total Liabilities	121.39B	124.90B	137.21B	101.29B	104.01B	90.76B	104.15B	95.66B	100.14B	111.78B
Shareholders' Equity	86.48B	88.20B	89.01B	95.66B	77.20B	63.24B	63.14B	63.41B	71.31B	59.54B
Retained Earnings	114.61B	116.72B	118.35B	125.66B	103.39B	90.39B	97.67B	89.55B	85.29B	71.77B
Total Debt	64.80B	64.35B	71.89B	35.83B	38.44B	39.84B	52.15B	41.74B	43.49B	42.09B
Net Cash (Debt)	-54.47B	-52.43B	-64.64B	-16.67B	-14.48B	-27.61B	-42.50B	-22.91B	-23.50B	-24.24B

This table shows 10 annual periods of Pfizer's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PFE's reporting calendar. What is a balance sheet?